Muscular Dystrophy Association Awards Venture Philanthropy Funding to PathMaker Neurosystems to Develop Neuromodulation Treatment for ALS
17 janv. 2023 06h00 HE
|
PathMaker Neurosystems Inc.
BOSTON and NEW YORK, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) and PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company...
Global Neurotechnology Market Report 2022: The Definitive Report on Neuromodulation, Neuroprosthetics, Neurodiagnostics, and Neurorehabilitation Devices
10 août 2022 05h13 HE
|
Research and Markets
Dublin, Aug. 10, 2022 (GLOBE NEWSWIRE) -- The "The Market for Neurotechnology: 2022-2026" report has been added to ResearchAndMarkets.com's offering. Overall worldwide market for neurotechnology...
Global Invasive Brain-Computer interface (BCI) Market Research Report 2022: Real-time Decoding of Macroscopic Brain States Becomes Critical
14 juin 2022 05h43 HE
|
Research and Markets
Dublin, June 14, 2022 (GLOBE NEWSWIRE) -- The "Market Overview of Invasive Brain-Computer interface (BCI)" report has been added to ResearchAndMarkets.com's offering. Patients with Locked-in...
PathMaker Neurosystems Initiates U.S. Multi-Center Trial Evaluating MyoRegulator® for the Non-Invasive Treatment of Post-Stroke Spasticity
07 mars 2022 06h00 HE
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, March 07, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc., (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
PathMaker Neurosystems Appoints Leading Neurotechnology Expert, John Donoghue, Ph.D., to Board of Directors
21 oct. 2021 05h00 HE
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
Heuro Canada First to Bring Revolutionary Neurological Health Technology to Canada
07 déc. 2018 05h00 HE
|
Heuro Canada
SURREY, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Heuro Canada Inc., a leading provider of innovative neurological health solutions, is championing a new therapeutic paradigm for...
Newly Published Market Research Report Projects Neurotechnology Market Will Reach $13.3B by 2022
23 avr. 2018 08h03 HE
|
Neurotech Reports
SAN FRANCISCO, April 23, 2018 (GLOBE NEWSWIRE) -- A newly published market research report from Neurotech Reports predicts that the global market for neurotechnology products will be $8.4 billion in...
![Om-logo-teal-150](http://www.globenewswire.com/fr/Attachment/LogoDisplay/269556?filename=269556.jpg&size=2)
Patient-Centered Primary Care Collaborative CEO Marci Nielsen To Kick-Off The 2013 OPEN MINDS Technology & Informatics Institute
01 oct. 2013 10h03 HE
|
Open Minds
GETTYSBURG, Pa., Oct. 1, 2013 (GLOBE NEWSWIRE) -- OPEN MINDS has announced that Marci Nielsen, Ph.D., MPH, Chief Executive Officer, Patient-Centered Primary Care Collaborative (PCPCC) will open The...
NovaVision's FDA-Cleared Visual Restoration Therapy (VRT) System and Company Assets Now Available
19 juil. 2010 08h00 HE
|
The Magnum Group
TIBURON, CA--(Marketwire - July 19, 2010) - NovaVision, Inc., headquartered in Boca Raton, Fla., filed for Chapter 7 Bankruptcy in the State of Florida (Case #10-21343-PGH) on April 28, 2010...